RxDoctor Payments Data

Mariah Franclemont, PA

Medical · Portland, ORNPI 1871909028

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (52.6%), food and beverage and education — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Inspire Medical Systems, Inc. at 52.6% of the total. Reporting peaked in 2024 at $1,168 and has fallen 61.1% since, to $454 in 2025.

$1,809in general payments, 2019–2025

Across 35 payments — averaging $51.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Inspire Medical Systems, Inc.$952
  • Axsome Therapeutics, Inc.$248
  • Avadel CNS Pharmaceuticals, LLC$175
  • Jazz Pharmaceuticals Inc.$159
  • Harmony Biosciences LLC$130
  • Lilly USA, LLC$53
  • plus $93 from 4 others

What the payments were for

  • Travel & lodging$95253%
  • Food & beverage$85447%
  • Education$30%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,809 in reported general payments places this provider in the 80th percentile of 364 medical providers in Oregon.

See all medical providers in Oregon

Medicare billing

Part B allowed, 2024
$54,226
Medicare patients
214
Services billed
763

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clonazepam13$445
Gabapentin19$291

Paid to pharmacies, not to this prescriber.

Other medical in Portland

See the full list for Oregon

Where these figures come from

Is this you, or does something look wrong? →